Segui
Umberto Malapelle
Umberto Malapelle
Department of Public Health, University Federico II of Naples
Email verificata su unina.it - Home page
Titolo
Citata da
Citata da
Anno
Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer
C Rolfo, P Mack, GV Scagliotti, C Aggarwal, ME Arcila, F Barlesi, T Bivona, ...
Journal of Thoracic Oncology 16 (10), 1647-1662, 2021
3262021
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer
U Malapelle, R Sirera, E Jantus-Lewintre, P Reclusa, S Calabuig-Fariñas, ...
Expert review of molecular diagnostics 17 (3), 209-215, 2017
1762017
CBX7 is a tumor suppressor in mice and humans
F Forzati, A Federico, P Pallante, A Abbate, F Esposito, U Malapelle, ...
The Journal of clinical investigation 122 (2), 2012
1672012
The evolving landscape of biomarker testing for non-small cell lung cancer in Europe
KM Kerr, F Bibeau, E Thunnissen, J Botling, A Ryška, J Wolf, K Öhrling, ...
Lung Cancer 154, 161-175, 2021
1352021
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients
U Malapelle, C Mayo de-Las-Casas, D Rocco, M Garzon, P Pisapia, ...
British Journal of Cancer 116 (6), 802-810, 2017
1242017
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
A Friedlaender, V Subbiah, A Russo, GL Banna, U Malapelle, C Rolfo, ...
Nature reviews Clinical oncology 19 (1), 51-69, 2022
1222022
SMO gene amplification and activation of the hedgehog pathway as novel mechanisms of resistance to anti-epidermal growth factor receptor drugs in human lung cancer
CM Della Corte, C Bellevicine, G Vicidomini, D Vitagliano, U Malapelle, ...
Clinical cancer research 21 (20), 4686-4697, 2015
1192015
Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models
R Rosa, R Marciano, U Malapelle, L Formisano, L Nappi, C D'Amato, ...
Clinical cancer research 19 (1), 138-147, 2013
1162013
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients
U Malapelle, P Pisapia, D Rocco, R Smeraglio, M di Spirito, C Bellevicine, ...
Translational lung cancer research 5 (5), 505, 2016
1112016
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)
C Rolfo, AF Cardona, M Cristofanilli, L Paz-Ares, JJD Mochon, I Duran, ...
Critical Reviews in Oncology/Hematology 151, 102978, 2020
1062020
The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal
V Gristina, U Malapelle, A Galvano, P Pisapia, F Pepe, C Rolfo, S Tortorici, ...
Cancer Treatment Reviews 85, 101994, 2020
1052020
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients
U Malapelle, E Vigliar, R Sgariglia, C Bellevicine, L Colarossi, D Vitale, ...
Journal of clinical pathology 68 (1), 64-68, 2015
1052015
Liquid biopsy and lung cancer
P Pisapia, U Malapelle, G Troncone
Acta cytologica 63 (6), 489-496, 2019
1022019
Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy)
D de Biase, M Visani, U Malapelle, F Simonato, V Cesari, C Bellevicine, ...
PloS one 8 (12), e83607, 2013
972013
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
N Fusco, E Sajjadi, K Venetis, G Gaudioso, G Lopez, C Corti, EG Rocco, ...
Genes 11 (7), 719, 2020
902020
EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study
U Malapelle, N de Rosa, D Rocco, C Bellevicine, C Crispino, A Illiano, ...
Journal of clinical pathology 65 (1), 87-91, 2012
902012
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review …
A Galvano, V Gristina, U Malapelle, P Pisapia, F Pepe, N Barraco, ...
ESMO open 6 (3), 100124, 2021
882021
Noninvasive biomarkers of colorectal cancer: role in diagnosis and personalised treatment perspectives
G Pellino, G Gallo, P Pallante, R Capasso, A De Stefano, I Maretto, ...
Gastroenterology research and practice 2018, 2018
882018
Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases
U Malapelle, P Pisapia, R Sgariglia, E Vigliar, M Biglietto, C Carlomagno, ...
Journal of clinical pathology 69 (9), 767-771, 2016
872016
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non–small cell lung carcinoma patients
U Malapelle, C Bellevicine, C De Luca, M Salatiello, A De Stefano, ...
Cancer cytopathology 121 (10), 552-560, 2013
862013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20